Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Tarsus Pharmaceuticals Inc
TARS | US
74.49
USD1.23
1.68%
TARS | US
About Tarsus Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
09/03/2026
Close
74.49
Open
72.65
High
74.77
Low
72.35
Tarsus Pharmaceuticals Inc. a biopharmaceutical company focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03 a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition the company develops lotilaner to address diseases across therapeutic categories in human medicine including eye care dermatology and other diseases. Tarsus Pharmaceuticals Inc. was incorporated in 2016 and is headquartered in Irvine California.
View LessTARS | US
Risk
47.9
Sharpe
1.44
Luna's Score
54/100
Recommendation
Hold
Luna says (TARS | US)
What's Working
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
54.1%1 month
47.9%3 months
39.7%6 months
43.0%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
5.59
Debt to equity
0.29
Debt to assets
0.19
Ent. to EBITDA
-3.23
Ent. to rev.
13.90
PEG
-
Other Fundamentals
EBITDA
-155.27M
MarketCap
2.83B
MarketCap(USD)
2.83B
Div. yield
-
Op. margin
-81.60
Erngs. growth
-
Rev. growth
1.00K
Ret. on equity
-75.04
Short ratio
14.63
Short perc.
27.12
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
14.25
Range1M
19.46
Range3M
24.71
Volumes: Market Activity
Rel. volume
0.62
Price X volume
30.22M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.23 | 0.53 | Cheaper |
| Ent. to Revenue | 13.90 | 3,967.00 | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 5.59 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 39.68 | 72.80 | Lower Risk |
| Debt to Equity | 0.29 | -1.23 | Expensive |
| Debt to Assets | 0.19 | 0.25 | Cheaper |
| Market Cap | 2.83B | 3.66B | Emerging |
